Literature DB >> 15217958

Novel agents in the treatment of lung cancer: conference summary statement.

Thomas J Lynch1, Alex A Adjei, Paul A Bunn, Raymond N DuBois, David R Gandara, Giuseppe Giaccone, Ramaswamy Govindan, Roy S Herbst, Bruce E Johnson, Fadlo R Khuri, Roman Perez-Soler, Rafael Rosell, Eric K Rowinsky, Alan B Sandler, Giorgio V Scagliotti, Joan H Schiller, Geoffrey I Shapiro, Mark A Socinski, Carol S Hart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15217958     DOI： 10.1158/1078-0432.CCR-040021

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  6 in total

1.  Topoisomerase I inhibitor SN-38 effectively attenuates growth of human non-small cell lung cancer cell lines in vitro and in vivo.

Authors:  Dharmendra Kumar Maurya; Rie Ayuzawa; Chiyo Doi; Deryl Troyer; Masaaki Tamura
Journal:  J Environ Pathol Toxicol Oncol       Date:  2011       Impact factor: 3.567

2.  Anticancer property of gallic acid in A549, a human lung adenocarcinoma cell line, and possible mechanisms.

Authors:  Dharmendra K Maurya; Nivedita Nandakumar; Thomas Paul Asir Devasagayam
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

3.  HER2 expression as a potential marker for response to therapy targeted to the EGFR.

Authors:  D R Emlet; R Schwartz; K A Brown; A A Pollice; C A Smith; S E Shackney
Journal:  Br J Cancer       Date:  2006-04-24       Impact factor: 7.640

4.  Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung.

Authors:  Neeta Somaiah; Mary Jo Fidler; Elizabeth Garrett-Mayer; Amy Wahlquist; Keisuke Shirai; Lela Buckingham; Thomas Hensing; Philip Bonomi; George R Simon
Journal:  Oncoscience       Date:  2014-08-07

5.  SH005S7 Overcomes Primary and Acquired Resistance of Non-Small Cell Lung Cancer by Combined MET/EGFR/HER3 Inhibition.

Authors:  Sooyeon Kang; Ji Hye Kim; Jisoo Hong; Ji Hong Moon; Yun Young Kwon; Seong-Gyu Ko
Journal:  Biomed Res Int       Date:  2022-09-15       Impact factor: 3.246

6.  Therapy with un-engineered naïve rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinoma.

Authors:  Dharmendra K Maurya; Chiyo Doi; Atsushi Kawabata; Marla M Pyle; Clay King; Zhihong Wu; Deryl Troyer; Masaaki Tamura
Journal:  BMC Cancer       Date:  2010-10-28       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.